Abstract
The invention relates to low molecular weight heparin used for treating and/or preventing liver fibrosis. For the low molecular weight heparin, the range of number-average molecular weight (Mn) is 2800-5000Da, the range of weight-average molecular weight (Mw) is 6100-13000Da, the range of optimal number-average molecular weight (Mn) is 3000-4500Da, the range of weight-average molecular weight (Mw)is 6200-12000Da, further, the range of optimal number-average molecular weight (Mn) is 3200-4400Da, the range of weight-average molecular weight (Mw) is 6300-11000Da, further, the range of optimal number-average molecular weight (Mn) is 3250-4200Da, and the range of weight-average molecular weight (Mw) is 6400-10500Da.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
